MELVILLE, N.Y., Dec. 21, 2021 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Firm” or “BioRestorative”) (NASDAQ:BRTX), a life sciences firm centered on grownup stem cell-based therapies, immediately introduced its Chief Government Officer, Lance Alstodt, can be featured on the James Hicks “NewMedia Present” on Tuesday, December 21st.
The NewMedia Present covers a spread of matters and present occasions. The present has a big neighborhood of subscribers curious about science, know-how, enterprise, sports activities and tradition. The NewMedia Present is seen and heard throughout a number of social media platforms, comparable to YouTube, LinkedIn, Fb, and Twitter.
“It’s an honor to be invited on the NewMedia Present with James Hicks. I’ve adopted his programming and I’m very impressed with the format of the present and the attain that he has inside his neighborhood. I sit up for the chance to inform our story, assessment our 2021 accomplishments in addition to present an replace for the approaching 12 months,” mentioned Lance Alstodt, CEO of BioRestorative Therapies.
The interview could also be accessed on the next YouTube channel hyperlink: https://t.co/ZRxhxvnwqW.
About BioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. (www.biorestorative.com) develops therapeutic merchandise utilizing cell and tissue protocols, primarily involving grownup stem cells. Our two core packages, as described under, relate to the therapy of disc/backbone illness and metabolic problems:
- Disc/Backbone Program (brtxDISC™): Our lead cell remedy candidate, BRTX-100, is a product formulated from autologous (or an individual’s personal) cultured mesenchymal stem cells collected from the affected person’s bone marrow. We intend that the product can be used for the non-surgical therapy of painful lumbosacral disc problems or as a complementary therapeutic to a surgical process. The BRTX-100 manufacturing course of makes use of proprietary know-how and entails accumulating a affected person’s bone marrow, isolating and culturing stem cells from the bone marrow and cryopreserving the cells. In an outpatient process, BRTX-100 is to be injected by a doctor into the affected person’s broken disc. The therapy is meant for sufferers whose ache has not been alleviated by non-invasive procedures and who doubtlessly face the prospect of surgical procedure. We have now obtained authorization from the Meals and Drug Administration to start a Part 2 medical trial utilizing BRTX-100 to deal with persistent decrease again ache arising from degenerative disc illness.
- Metabolic Program (ThermoStem®): We’re growing a cell-based remedy candidate to focus on weight problems and metabolic problems utilizing brown adipose (fats) derived stem cells to generate brown adipose tissue (“BAT”). BAT is meant to imitate naturally occurring brown adipose depots that regulate metabolic homeostasis in people. Preliminary preclinical analysis signifies that elevated quantities of brown fats in animals could also be liable for extra caloric burning in addition to lowered glucose and lipid ranges. Researchers have discovered that folks with larger ranges of brown fats could have a lowered danger for weight problems and diabetes.
Ahead-Wanting Statements
This press launch accommodates “forward-looking statements” inside the which means of Part 27A of the Securities Act of 1933, as amended, and Part 21E of the Securities Change Act of 1934, as amended, and such forward-looking statements are made pursuant to the secure harbor provisions of the Non-public Securities Litigation Reform Act of 1995. You’re cautioned that such statements are topic to a large number of dangers and uncertainties that might trigger future circumstances, occasions or outcomes to vary materially from these projected within the forward-looking statements on account of numerous elements and different dangers, together with, with out limitation, these set forth within the Firm’s newest Type 10-Okay filed with the Securities and Change Fee. You must think about these elements in evaluating the forward-looking statements included herein, and never place undue reliance on such statements. The forward-looking statements on this launch are made as of the date hereof and the Firm undertakes no obligation to replace such statements.
CONTACT:
E mail: ir@biorestorative.com
